AeroPace® System
FDA premarket approval P240012/S003 · decided 2025-09-29
Approval details
- PMA number
- P240012
- Supplement
- S003
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- AeroPace® System
- Generic name
- Transvenous temporary phrenic nerve stimulator
- Applicant
- Lungpacer Medical USA, Inc.
- Date received
- 2025-08-20
- Decision date
- 2025-09-29
- Days to decision
- 40 days
- Decision code
- APPR
- Product code
- SDL
- Advisory committee
- Anesthesiology
- Expedited review
- No
- Location
- Exton, PA
- Statement
- Approval for software changes to the breath detection algorithm and baseline pressure calculation.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.